InvestorsHub Logo
Followers 19
Posts 901
Boards Moderated 0
Alias Born 05/31/2013

Re: hschlauch post# 45335

Tuesday, 09/18/2018 9:18:27 AM

Tuesday, September 18, 2018 9:18:27 AM

Post# of 48316
Hsch, You’re actually confirming my suspicions since the reception that I attended last April. The pieces trail Appears to be developing a baseline for Tavo with the PD-1. And that I doubt anything will come out of it, since the science has already developed beyond this basic combination and immunotherapy need to multi-gene cocktail With IL-12 at the base.

I can also tell that you’re not as big and the disruptive element, and that all ONCS—Rather than being at a point of licensing or buy out – – is simply turning the corner to head down another 2 to 3 years out research runway as they explore their multi-gene construct with the aid of Dr. Lo’s findings.

Am I reading you correctly hsch?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News